# Self-testing tilted strategies for maximal loophole-free nonlocality

Article · N. Gigena, Ekta Panwar, Giovanni Scala, Mateus Araújo, Máté Farkas, Anubhav Chaturvedi

- Archive id: arxiv:2405.08743
- Published: 2025-05-19
- Venue: npj Quantum Information
- DOI: https://doi.org/10.1038/s41534-025-01029-6
- arXiv: https://arxiv.org/abs/2405.08743
- Citations: 7
- Source URL: https://doi.org/10.1038/s41534-025-01029-6
- PDF: https://www.nature.com/articles/s41534-025-01029-6.pdf
- Provenance: openalex+arxiv

## Abstract

The degree of experimentally attainable nonlocality, as gauged by the loophole-free or effective violation of Bell inequalities, remains severely limited due to inefficient detectors. We address an experimentally motivated question: Which quantum strategies attain the maximal loophole-free nonlocality in the presence of inefficient detectors? For any Bell inequality and any specification of detection efficiencies, the optimal strategies are those that maximally violate a tilted version of the Bell inequality in ideal conditions. In the simplest scenario, we demonstrate that the quantum strategies that maximally violate the doubly-tilted versions of Clauser-Horne-Shimony-Holt inequality are unique up to local isometries. We utilize a Jordan's lemma and Gröbner basis-based proof technique to analytically derive self-testing statements for the entire family of doubly-tilted CHSH inequalities and numerically demonstrate their robustness. These results enable us to reveal the insufficiency of even high levels of the Navascués--Pironio--Acín hierarchy to saturate the maximum quantum violation of these inequalities.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Quantum Foundations](https://space-kitty.com/topics/quantum-foundations)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.